Long-term outcomes of baseline grey-zone patients with HBeAg-negative chronic hepatitis B virus infection
The outcomes of patients with grey-zone HBeAg-negative chronic HBV infection remain uncertain, hindering their optimal management and timely treatment in clinical practice. Our real-world data from a tertiary HBV center provide valuable insights to guide the management of this patient group. Grey-zone HBeAg-negative patients represent a substantial proportion of the chronic HBV population and require careful monitoring, as they are at increased risk of hepatocellular carcinoma and other liver-related events.
Authors
- Sofia Paraskevopoulou (ORCID: https://orcid.org/0000-0003-2608-2596)
- Paraskevi Fytili
- Dimitrios S. Karagiannakis (ORCID: https://orcid.org/0000-0003-0082-634X)
- Alkistis Papatheodoridi (ORCID: https://orcid.org/0000-0001-6248-6964)
- Stratigoula Sakellariou (ORCID: https://orcid.org/0000-0002-3639-6807)
- George Papatheodoridis
- Ioannis Vlachogiannakos
- Panagiota Ioannidou
- Margarita Papatheodoridi
- Evangelos Cholongitas
Institutions
- National and Kapodistrian University of Athens (GR)
- Laiko General Hospital of Athens (GR)
Publication Details
- Journal
- JHEP Reports
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1016/j.jhepr.2026.101771
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00